Foghorn Therapeutics (FHTX) Cash from Investing Activities Growth (1y) (2020 - 2026)
Foghorn Therapeutics (FHTX) Cash from Investing Activities Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Foghorn Therapeutics |
282.33 Mn |
193.42 Mn |
- |
-160.27% |
| Date | Value |
|---|
| Mar 31, 2026 |
-160.27% |
| Dec 31, 2025 |
-40.64% |
| Sep 30, 2025 |
158.02% |
| Jun 30, 2025 |
288.23% |
| Mar 31, 2025 |
8.51% |
| Dec 31, 2024 |
-40.37% |
| Sep 30, 2024 |
-259.57% |
| Jun 30, 2024 |
-145.93% |
| Mar 31, 2024 |
-8.17% |
| Dec 31, 2023 |
674.54% |
| Sep 30, 2023 |
-16.56% |
| Jun 30, 2023 |
131.44% |
| Mar 31, 2023 |
118.51% |
| Dec 31, 2022 |
-167.27% |
| Sep 30, 2022 |
197.30% |
| Jun 30, 2022 |
-261.45% |
| Mar 31, 2022 |
-4,788.35% |
| Dec 31, 2021 |
109.65% |
| Sep 30, 2021 |
-772.41% |
| Jun 30, 2021 |
3,529.23% |
